Category Health/Medical

New CRISPR Technology ‘Knocks Out’ Yeast Genes with Single-Point Precision

Image result for : CHAnGE enables rapid generation of genome-wide yeast disruption mutants and directed evolution of complex phenotypes.

CHAnGE enables rapid generation of genome-wide yeast disruption mutants and directed evolution of complex phenotypes.

The CRISPR-Cas9 system has given researchers the power to precisely edit selected genes. Now, researchers have used it to develop a technology that can target any gene in the yeast Saccharomyces cerevisiae and turn it off by deleting single letters from its DNA sequence. Such genome-scale engineering – in contrast to traditional strategies that only target a single gene or a limited number of genes – allows researchers to study the role of each gene individually, as well as in combination with other genes. It also could be useful for industry, where S. cerevisiae is widely used to produce ethanol, industrial chemicals, lubricants, pharmaceuticals and more.

Understanding and...

Read More

Universal Antibody Drug for HIV-1 Prevention and Immunotherapy

Design and characterization of 5 IAs.(A, B) Schematic diagrams show the...

Design and characterization of 5 IAs. (A, B) Schematic diagrams show the structures of IAs, which are scFv-hIgG-Fc–like molecules bearing antibody-binding domains to gp120 or human CD4. scFv, single-chain variable fragment; hIgG, human immunoglobulin G, VH, variable heavy chain; VL, variable light chain; CH, constant heavy chain. (C) The released IAs in culture supernatants were detected by Western blot analysis under reducing conditions. (D) Each IA displayed neutralizing activity against pseudovirus HIV-1ADA. (E) Paired IAs were tested for synergistic effects in a checkerboard neutralization assay. The synergy volumes of –50 to 50, 50 to 100, and >100 in a synergy plot at the 95% CI were used to define additive, slight synergistic, and synergistic effects, respectively...

Read More

Microbeads to Combat Infection show promise in Burn Wound simulations

Diagrams showing the burn wound geometry (left) and a cartoon representation of the mathematical model (right). Host cells are covered by a liquid layer known as the exudate, which is itself covered by dead (necrotic) tissue, except in the region of the excision where the exudate is exposed to the air. Bacteria and inhibitors exist in one of two states: free in the exudate or bound to the host cells, and can transition between these states by binding to and unbinding from the host cells. Both free and bound bacteria can divide; daughters of free bacteria enter the exudate, whereas some of the bound bacterial daughters remain bound to the surface, the rest entering the exudate. Bound bacteria may be consumed and destroyed (phagocytosed) by immune cells called neutrophils, while free bacteria and inhibitors may leak out of the wound (clearance) in the first twenty-four hours after the excision is made and before a scab forms over the exposed exudate. Credit: Image created by Dr. Paul A. Roberts. CC-BY

Diagrams showing the burn wound geometry (left) and a cartoon representation of the mathematical model (right). Host cells are covered by a liquid layer known as the exudate, which is itself covered by dead (necrotic) tissue, except in the region of the excision where the exudate is exposed to the air. Bacteria and inhibitors exist in one of two states: free in the exudate or bound to the host cells, and can transition between these states by binding to and unbinding from the host cells. Both free and bound bacteria can divide; daughters of free bacteria enter the exudate, whereas some of the bound bacterial daughters remain bound to the surface, the rest entering the exudate...

Read More

Bacteria Therapy for Eczema shows promise

A scientist demonstrates application of the experimental therapy to the inner elbow. For demonstration purposes, the bacteria solution has been replaced with purple dye. Credit: NIAID

A scientist demonstrates application of the experimental therapy to the inner elbow. For demonstration purposes, the bacteria solution has been replaced with purple dye. Credit: NIAID

Topical treatment with live Roseomonas mucosa – a bacterium naturally present on the skin – was safe for adults and children with atopic dermatitis (eczema) and was associated with reduced disease severity, according to initial findings from an ongoing early-phase clinical trial at the National Institutes of Health. Preclinical work in a mouse model of atopic dermatitis had suggested that R. mucosa strains collected from healthy skin can relieve disease symptoms. The new findings, published May 3 in JCI Insight, support further evaluation of this potential new therapy.

Atopic dermatitis is an inflammatory ski...

Read More